Patent delisted for IMPAX drug TWINJECT 0.15
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA. […]
Patent Expiration
Patent delisted for Merck Sharp drug PREVYMIS
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Patent delisted for Boehringer Ingelheim drug GLYXAMBI
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
Patent delisted for Veloxis Pharms drug ENVARSUS XR
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Patent delisted for Otsuka drug ABILIFY MYCITE KIT
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
Patent delisted for Otsuka drug ABILIFY MYCITE KIT Read Post »
Patent delisted for Taiho Oncology drug LONSURF
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA.
Patent delisted for Purdue Pharma drug TARGINIQ
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one
Patent delisted for Boehringer Ingelheim drug OFEV
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
